Insider · CIK 0001746342
Carmen Chang
ownerdirector
Files at COUR (Coursera, Inc.), NEUE (NeueHealth, Inc.), KRRO (Korro Bio, Inc.), SGP (SpyGlass Pharma, Inc.). First filing Oct 6, 2025, latest Mar 12, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 1
$17M bought, $26k sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
KRRO: Korro Bio, Inc.
KRROOct 9, 2026 · close 10.16
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
SGP: SpyGlass Pharma, Inc.
SGPOct 9, 2026 · close 24.92
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Korro Bio, Inc. | $2.3M 207,100 shares | +19% | +117% from low-78% from high | |
| 50Moderate | SpyGlass Pharma, Inc. | $15M 937,500 shares | +18% | - | |
| 20Weak | NeueHealth, Inc. | $26k 3,915 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | COUR Coursera, Inc. | AGrant or award Common Stock | +34,260 | $0.00 | $0 | 122,520 | Jun 15, 2026 |
| Mar 10, 2026 | KRRO Korro Bio, Inc. | POpen-market purchase Common Stockindirect: See Note 2 | +207,100 | $11.11 | $2.3M | 1,297,893 | Mar 12, 2026 |
| Mar 10, 2026 | KRRO Korro Bio, Inc. | POpen-market purchase Pre-Funded Warrantsderivativeindirect: See Note 2 | +242,945 | $11.11 | $2.7M | 242,945 | Mar 12, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stockindirect: See Note 2 | +1,619,240 | - | - | 1,619,240 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stockindirect: See Note 2 | +1,370,168 | - | - | 2,989,408 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stockindirect: See Note 2 | +1,370,168 | - | - | 4,359,576 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stockindirect: See Note 2 | +737,962 | - | - | 5,097,538 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | POpen-market purchase Common Stockindirect: See Note 2 | +937,500 | $16.00 | $15M | 6,035,038 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stockindirect: See Note 3 | +954,990 | - | - | 954,990 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Common Stockindirect: See Note 3 | +402,273 | - | - | 1,357,263 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series B Preferred Stockderivativeindirect: See Note 2 | -1,619,240 | - | - | 0 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series C-1 Preferred Stockderivativeindirect: See Note 2 | -1,370,168 | - | - | 0 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series C-2 Preferred Stockderivativeindirect: See Note 2 | -1,370,168 | - | - | 0 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series D Preferred Stockderivativeindirect: See Note 2 | -737,962 | - | - | 0 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series A Preferred Stockderivativeindirect: See Note 3 | -954,990 | - | - | 0 | Feb 11, 2026 |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | CConversion Series B Preferred Stockderivativeindirect: See Note 3 | -402,273 | - | - | 0 | Feb 11, 2026 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stockindirect: See Note 1 | +189,195 | $0.01 | $1,892 | 788,259 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stockindirect: See Note 1 | -280 | $6.75 | $1,890 | 787,979 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Common Stockindirect: See Note 1 | +372,255 | $0.01 | $3,723 | 1,160,234 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | FTax withholding Common Stockindirect: See Note 1 | -551 | $6.75 | $3,719 | 1,159,683 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Common Stockindirect: See Note 1 | -1,159,683 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stockindirect: See Note 4 | +189,195 | $0.01 | $1,892 | 488,982 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stockindirect: See Note 4 | -280 | $6.75 | $1,890 | 488,702 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Common Stockindirect: See Note 4 | +186,128 | $0.01 | $1,861 | 674,830 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | FTax withholding Common Stockindirect: See Note 4 | -276 | $6.75 | $1,863 | 674,554 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Common Stockindirect: See Note 4 | -674,554 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stockindirect: See Note 5 | +1,656,789 | $0.01 | $17k | 1,656,789 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stockindirect: See Note 5 | -2,455 | $6.75 | $17k | 1,654,334 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stockindirect: See Note 5 | +607,536 | $0.01 | $6,075 | 2,261,870 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stockindirect: See Note 5 | -900 | $6.75 | $6,075 | 2,260,970 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Common Stockindirect: See Note 5 | +124,085 | $0.01 | $1,241 | 2,385,055 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | FTax withholding Common Stockindirect: See Note 5 | -182 | $6.75 | $1,229 | 2,384,873 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Common Stockindirect: See Note 5 | -2,384,873 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Note 1 | -189,195 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | AGrant or award Warrant (Right to Buy)derivativeindirect: See Note 1 | +372,255 | - | - | 372,255 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Warrant (Right to Buy)derivativeindirect: See Note 1 | -372,255 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Note 4 | -189,195 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | AGrant or award Warrant (Right to Buy)derivativeindirect: See Note 4 | +186,128 | - | - | 186,128 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Warrant (Right to Buy)derivativeindirect: See Note 4 | -186,128 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series A Convertible Perpetual Preferred Stockderivativeindirect: See Note 4 | -75,000 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series B Convertible Perpetual Preferred Stockderivativeindirect: See Note 4 | -37,700 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Note 5 | -1,656,789 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Note 5 | -607,536 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | AGrant or award Warrant (Right to Buy)derivativeindirect: See Note 5 | +124,085 | - | - | 124,085 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Warrant (Right to Buy)derivativeindirect: See Note 5 | -124,085 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series A Convertible Perpetual Preferred Stockderivativeindirect: See Note 5 | -125,000 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series B Convertible Perpetual Preferred Stockderivativeindirect: See Note 5 | -100,000 | - | - | 0 | Oct 6, 2025 |
| May 21, 2025 | COUR Coursera, Inc. | AGrant or award Common Stock | +21,765 | $0.00 | $0 | 88,260 | May 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.